221 related articles for article (PubMed ID: 10082583)
1. cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity.
Kitzmann M; Vandromme M; Schaeffer V; Carnac G; Labbé JC; Lamb N; Fernandez A
Mol Cell Biol; 1999 Apr; 19(4):3167-76. PubMed ID: 10082583
[TBL] [Abstract][Full Text] [Related]
2. p57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts.
Reynaud EG; Pelpel K; Guillier M; Leibovitch MP; Leibovitch SA
Mol Cell Biol; 1999 Nov; 19(11):7621-9. PubMed ID: 10523650
[TBL] [Abstract][Full Text] [Related]
3. Cyclin E-cdk2 phosphorylation promotes late G1-phase degradation of MyoD in muscle cells.
Tintignac LA; Leibovitch MP; Kitzmann M; Fernandez A; Ducommun B; Meijer L; Leibovitch SA
Exp Cell Res; 2000 Aug; 259(1):300-7. PubMed ID: 10942602
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of MyoD by direct binding to p57(Kip2).
Reynaud EG; Leibovitch MP; Tintignac LA; Pelpel K; Guillier M; Leibovitch SA
J Biol Chem; 2000 Jun; 275(25):18767-76. PubMed ID: 10764802
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of the myristoylated protein kinase C substrate MARCKS by the cyclin E-cyclin-dependent kinase 2 complex in vitro.
Manenti S; Yamauchi E; Sorokine O; Knibiehler M; Van Dorsselaer A; Taniguchi H; Ducommun B; Darbon JM
Biochem J; 1999 Jun; 340 ( Pt 3)(Pt 3):775-82. PubMed ID: 10359664
[TBL] [Abstract][Full Text] [Related]
6. Human T-cell leukemia virus type 1 tax protein inhibits the expression of the basic helix-loop-helix transcription factor MyoD in muscle cells: maintenance of proliferation and repression of differentiation.
Riou P; Vandromme M; Gazzolo L
Cell Growth Differ; 2001 Dec; 12(12):613-22. PubMed ID: 11751456
[TBL] [Abstract][Full Text] [Related]
7. Varicella-zoster virus Fc receptor component gI is phosphorylated on its endodomain by a cyclin-dependent kinase.
Ye M; Duus KM; Peng J; Price DH; Grose C
J Virol; 1999 Feb; 73(2):1320-30. PubMed ID: 9882337
[TBL] [Abstract][Full Text] [Related]
8. Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry.
Tintignac LA; Sirri V; Leibovitch MP; Lécluse Y; Castedo M; Metivier D; Kroemer G; Leibovitch SA
Mol Cell Biol; 2004 Feb; 24(4):1809-21. PubMed ID: 14749395
[TBL] [Abstract][Full Text] [Related]
9. Mutation of MyoD-Ser237 abolishes its up-regulation by c-Mos.
Pelpel K; Leibovitch M; Fernandez A; Leibovitch SA
FEBS Lett; 2000 Jun; 474(2-3):233-7. PubMed ID: 10838091
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I extends in vitro replicative life span of skeletal muscle satellite cells by enhancing G1/S cell cycle progression via the activation of phosphatidylinositol 3'-kinase/Akt signaling pathway.
Chakravarthy MV; Abraha TW; Schwartz RJ; Fiorotto ML; Booth FW
J Biol Chem; 2000 Nov; 275(46):35942-52. PubMed ID: 10962000
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of human estrogen receptor alpha transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex.
Rogatsky I; Trowbridge JM; Garabedian MJ
J Biol Chem; 1999 Aug; 274(32):22296-302. PubMed ID: 10428798
[TBL] [Abstract][Full Text] [Related]
12. Cdk2 kinase phosphorylates serine 315 of human p53 in vitro.
Price BD; Hughes-Davies L; Park SJ
Oncogene; 1995 Jul; 11(1):73-80. PubMed ID: 7624134
[TBL] [Abstract][Full Text] [Related]
13. Cdc25 regulates the phosphorylation and activity of the Xenopus cdk2 protein kinase complex.
Gabrielli BG; Lee MS; Walker DH; Piwnica-Worms H; Maller JL
J Biol Chem; 1992 Sep; 267(25):18040-6. PubMed ID: 1517236
[TBL] [Abstract][Full Text] [Related]
14. Identification of cyclin A/Cdk2 phosphorylation sites in B-Myb.
Bartsch O; Horstmann S; Toprak K; Klempnauer KH; Ferrari S
Eur J Biochem; 1999 Mar; 260(2):384-91. PubMed ID: 10095772
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts.
Kitzmann M; Fernandez A
Cell Mol Life Sci; 2001 Apr; 58(4):571-9. PubMed ID: 11361092
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase.
Skapek SX; Rhee J; Spicer DB; Lassar AB
Science; 1995 Feb; 267(5200):1022-4. PubMed ID: 7863328
[TBL] [Abstract][Full Text] [Related]
17. Degradation of cyclin A does not require its phosphorylation by CDC2 and cyclin-dependent kinase 2.
Yam CH; Siu WY; Lau A; Poon RY
J Biol Chem; 2000 Feb; 275(5):3158-67. PubMed ID: 10652300
[TBL] [Abstract][Full Text] [Related]
18. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.
Saville MK; Watson RJ
Oncogene; 1998 Nov; 17(21):2679-89. PubMed ID: 9840932
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha inhibits myogenic differentiation through MyoD protein destabilization.
Langen RC; Van Der Velden JL; Schols AM; Kelders MC; Wouters EF; Janssen-Heininger YM
FASEB J; 2004 Feb; 18(2):227-37. PubMed ID: 14769817
[TBL] [Abstract][Full Text] [Related]
20. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
Liu LN; Dias P; Houghton PJ
Cell Growth Differ; 1998 Sep; 9(9):699-711. PubMed ID: 9751114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
